Condition

Adverse Effects

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions5

Lead sponsors shown3

Clinical trials

3 shown

REBECCA - Research in Rehabilitation After Breast CancerNCT02056483 · 2013-07-01

COMPLETED

Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side EffectsNCT00696839 · 2008-09-01

COMPLETED

Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced NephropathyNCT00492518 · 2002-02-01

COMPLETED

Common interventions

AcetylcysteineDRUG1 Cognitive-behavioral therapyBEHAVIORAL1 PlaceboDRUG1 Screening-based nurse navigationOTHER1 TheophyllineDRUG1

Leading sponsors

Danish Cancer Society1 Duquesne University1 Technical University of Munich1

Trial status mix

COMPLETED3

Phase mix

NA2

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.